Unknown

Dataset Information

0

Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes.


ABSTRACT: Artemisinin derivatives are used in combination with other antimalarial drugs for treatment of multidrug-resistant malaria worldwide. Clinical resistance to artemisinin recently emerged in southeast Asia, yet in vitro phenotypes for discerning mechanism(s) of resistance remain elusive. Here, we describe novel phenotypic resistance traits expressed by artemisinin-resistant Plasmodium falciparum. The resistant parasites exhibit altered patterns of development that result in reduced exposure to drug at the most susceptible stage of development in erythrocytes (trophozoites) and increased exposure in the most resistant stage (rings). In addition, a novel in vitro delayed clearance assay (DCA) that assesses drug effects on asexual stages was found to correlate with parasite clearance half-life in vivo as well as with mutations in the Kelch domain gene associated with resistance (Pf3D7_1343700). Importantly, all of the resistance phenotypes were stable in cloned parasites for more than 2 years without drug pressure. The results demonstrate artemisinin-resistant P. falciparum has evolved a novel mechanism of phenotypic resistance to artemisinin drugs linked to abnormal cell cycle regulation. These results offer insights into a novel mechanism of drug resistance in P. falciparum and new tools for monitoring the spread of artemisinin resistance.

SUBMITTER: Hott A 

PROVIDER: S-EPMC4432152 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Artemisinin-resistant Plasmodium falciparum parasites exhibit altered patterns of development in infected erythrocytes.

Hott Amanda A   Casandra Debora D   Sparks Kansas N KN   Morton Lindsay C LC   Castanares Geocel-Grace GG   Rutter Amanda A   Kyle Dennis E DE  

Antimicrobial agents and chemotherapy 20150316 6


Artemisinin derivatives are used in combination with other antimalarial drugs for treatment of multidrug-resistant malaria worldwide. Clinical resistance to artemisinin recently emerged in southeast Asia, yet in vitro phenotypes for discerning mechanism(s) of resistance remain elusive. Here, we describe novel phenotypic resistance traits expressed by artemisinin-resistant Plasmodium falciparum. The resistant parasites exhibit altered patterns of development that result in reduced exposure to dru  ...[more]

Similar Datasets

| S-EPMC4992992 | biostudies-literature
| S-EPMC6978834 | biostudies-literature
| S-EPMC4545236 | biostudies-literature
| S-EPMC4668880 | biostudies-other
| S-EPMC7050989 | biostudies-literature
| S-EPMC7541349 | biostudies-literature
| S-EPMC7708629 | biostudies-literature
| S-EPMC7797096 | biostudies-literature
| S-EPMC3807790 | biostudies-literature
| S-EPMC5007947 | biostudies-literature